Gene-editing startup backed by Google Ventures raises $58M
Google Ventures-backed Verve Therapeutics — which has its headquarters in Cambridge, Mass, and reserarch labs at the Pennovation Center in West Philadelphia — raised $58 million.
The company is focused on using gene editing to treat and prevent heart disease.
Among Verve’s co-founders are Dr. Kiran Musunuru, an associate professor o f cardiovascular medicine and genetics at the Perelman School of Medicine at the University of Pennsylvania. Musunuru is serving as Verve’s scientific advisor.…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: John George Source Type: news
More News: Cardiology | Cardiovascular | Genetics | Health Management | Heart | Heart Disease | University of Pennsylvania